In line with the observation that the absolute mRNA expression level of a gene does not necessarily determine its importance in a given biological system, we have computationally predicted that the molecule PHAX is “rewired” in ccRCC patients treated with sunitinib compared to untreated patients with a comparable disease profile. The gene discussed is PHAX; the disease is nonpapillary renal cell carcinoma.